» Articles » PMID: 27162548

Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics

Overview
Journal Theranostics
Date 2016 May 11
PMID 27162548
Citations 215
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer metastasis accounts for the high mortality of many types of cancer. Owing to the unique advantages of high specificity and minimal invasiveness, photothermal therapy (PTT) has been evidenced with great potential in treating cancer metastasis. In this review, we outline the current approaches of PTT with respect to its application in treating metastatic cancer. PTT can be used alone, guided with multimodal imaging, or combined with the current available therapies for effective treatment of cancer metastasis. Numerous types of photothermal nanotherapeutics (PTN) have been developed with encouraging therapeutic efficacy on metastatic cancer in many preclinical animal experiments. We summarize the design and performance of various PTN in PTT alone and their combinational therapy. We also point out the lacking area and the most promising approaches in this challenging field. In conclusion, PTT or their combinational therapy can provide an essential promising therapeutic modality against cancer metastasis.

Citing Articles

pH-Activated Nanoplatform Derived from M1 Macrophages' Exosomes for Photodynamic and Ferroptosis Synergistic Therapy to Augment Cancer Immunotherapy.

Guo Y, Qian R, Wei X, Yang C, Cao J, Hou X Biomater Res. 2025; 29:0153.

PMID: 40051791 PMC: 11883086. DOI: 10.34133/bmr.0153.


Ultrasound-mediated nanomaterials for the treatment of inflammatory diseases.

Zhang K, Wang T, Huang X, Wu P, Shen L, Yang Y Ultrason Sonochem. 2025; 114:107270.

PMID: 39961217 PMC: 11875835. DOI: 10.1016/j.ultsonch.2025.107270.


Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.

Tang L, Yang X, He L, Zhu C, Chen Q Lipids Health Dis. 2025; 24(1):31.

PMID: 39891269 PMC: 11783920. DOI: 10.1186/s12944-024-02429-x.


Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals.

Hashim G, Shahgolzari M, Hefferon K, Yavari A, Venkataraman S Bioengineering (Basel). 2025; 12(1).

PMID: 39851281 PMC: 11759177. DOI: 10.3390/bioengineering12010007.


Bright NIR-II emissive cyanine dye-loaded lipoprotein-mimicking nanoparticles for fluorescence imaging-guided and targeted NIR-II photothermal therapy of subcutaneous glioblastoma.

Huang H, Li M, Gu J, Roy S, Jin J, Kuang T J Nanobiotechnology. 2024; 22(1):788.

PMID: 39710705 PMC: 11665114. DOI: 10.1186/s12951-024-03074-3.


References
1.
Henderson T, Morries L . Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?. Neuropsychiatr Dis Treat. 2015; 11:2191-208. PMC: 4552256. DOI: 10.2147/NDT.S78182. View

2.
Guo L, Yan D, Yang D, Li Y, Wang X, Zalewski O . Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. ACS Nano. 2014; 8(6):5670-81. PMC: 4072412. DOI: 10.1021/nn5002112. View

3.
Deng H, Zhong Y, Du M, Liu Q, Fan Z, Dai F . Theranostic self-assembly structure of gold nanoparticles for NIR photothermal therapy and X-Ray computed tomography imaging. Theranostics. 2014; 4(9):904-18. PMC: 4107291. DOI: 10.7150/thno.9448. View

4.
Okuno T, Kato S, Hatakeyama Y, Okajima J, Maruyama S, Sakamoto M . Photothermal therapy of tumors in lymph nodes using gold nanorods and near-infrared laser light. J Control Release. 2013; 172(3):879-84. DOI: 10.1016/j.jconrel.2013.10.014. View

5.
Owonikoko T, Arbiser J, Zelnak A, Shu H, Shim H, Robin A . Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014; 11(4):203-22. PMC: 4041037. DOI: 10.1038/nrclinonc.2014.25. View